Under the condition that the cGAS-STING pathway is activated within the BRCA TME, increased persistence of T helper/IL-17-producing CD8+ T -generated CAR-T cells is observed in the TME and enhanced tumor control (15). The gene discussed is STING1; the disease is invasive breast carcinoma.